Masaru Matsuda

2021

In 2021, Masaru Matsuda earned a total compensation of $2.8M as Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary at Halozyme Therapeutics, a 61% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$205,920
Option Awards$450,010
Salary$457,600
Stock Awards$1,050,040
Other$594,459
Total$2,758,029

Matsuda received $1.1M in stock awards, accounting for 38% of the total pay in 2021.

Matsuda also received $205.9K in non-equity incentive plan, $450K in option awards, $457.6K in salary and $594.5K in other compensation.

Rankings

In 2021, Masaru Matsuda's compensation ranked 4,766th out of 12,412 executives tracked by ExecPay. In other words, Matsuda earned more than 61.6% of executives.

ClassificationRankingPercentile
All
4,766
out of 12,412
62nd
Division
Manufacturing
1,983
out of 5,498
64th
Major group
Chemicals And Allied Products
834
out of 2,374
65th
Industry group
Drugs
746
out of 2,095
64th
Industry
Biological Products, Except Diagnostic Substances
188
out of 452
58th

Pay ratio

Masaru Matsuda's Pay$2,758,029
Median Employee's Pay$291,734
Pay Ratio

9

to 1

In 2021, the annual total compensation of Masaru Matsuda was $2,758,029.

The annual total compensation of the median employee at Halozyme Therapeutics was $291,734.

The ratio of Masaru Matsuda's pay to the pay of median employee was therefore 9 to one.

Source: SEC filing on March 25, 2022.

Matsuda's colleagues

We found three more compensation records of executives who worked with Masaru Matsuda at Halozyme Therapeutics in 2021.

2021

Helen Torley

Halozyme Therapeutics

Chief Executive Officer

2021

Michael LaBarre

Halozyme Therapeutics

Senior Vice President, Chief Technical Officer

2021

Elaine Sun

Halozyme Therapeutics

Chief Financial Officer

News

You may also like